Publications
FILTER BY TYPE
Statement
BIO, DCVMN International & IFPMA
May 28, 2024
WHA77 constituency statement on INB – BY IFPMA, GSCF, GMTA, DVCMN, BIO
Publication
Elsevier
May 23, 2024
Accelerating sustainable regional vaccine manufacturing through global partnerships – 24th DCVMN Annual General meeting 2023 report
Publication
Health Policy Watch
May 22, 2024
The Pandemic Agreement: A Bridge to Nowhere or North Star to Access and Global Health Security?
Statement
IFPMA
March 11, 2024
Delivering equitable access in pandemics: Biopharmaceutical industry commitments – BY IFPMA, BIO, DCVMN, EFPIA, JPMA, PhRMA
Scientific Article
BMJ
March 6, 2024
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group – BMJ Global Health
Scientific Article
Elsevier
December 1, 2023
Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
Scientific Article
Preprint
November 6, 2023
Potency Testing of Whole-Cell Pertussis Containing Vaccines: Lesson Learned in a Multi-Laboratory Assessment of the Pertussis Serological Potency Test
Publication
Elsevier
July 13, 2023
Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report
Publication
GAVI
July 6, 2023
Vaccine patches could transform immunisation coverage in lower-income countries
Scientific Article
AIChE
February 1, 2023
Innovative vaccine packaging technologies: Perspectives on benefits and challenges of compact prefilled auto-disable devices and polymer containers
Our sponsors
Our sponsors
Our sponsors
Our sponsors
